These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1665065

  • 21. The partial purification of Clostridium perfringens beta toxin.
    Worthington RW, Mülders MS.
    Onderstepoort J Vet Res; 1975 Sep; 42(3):91-8. PubMed ID: 172828
    [Abstract] [Full Text] [Related]

  • 22. [Characteristics of the proteolytic complex of Clostridium perfringens type A].
    Novoselova GN, Efimova NP.
    Prikl Biokhim Mikrobiol; 1976 Sep; 12(6):890-903. PubMed ID: 191802
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Role of RNase Y in Clostridium perfringens mRNA Decay and Processing.
    Obana N, Nakamura K, Nomura N.
    J Bacteriol; 2017 Jan 15; 199(2):. PubMed ID: 27821608
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Degradation of C1q, the first subcomponent of the complement sequence, by synovial collagenase from patients with rheumatoid arthritis (author's transl)].
    Menzel EJ, Smolen JS.
    Wien Klin Wochenschr; 1978 Oct 27; 90(20):727-30. PubMed ID: 213903
    [Abstract] [Full Text] [Related]

  • 28. Characterization of an important enzymatic component in collagenase that is essential for the effective digestion of the human and porcine pancreas.
    Chen RL, James RF.
    Cell Transplant; 2001 Oct 27; 10(8):709-16. PubMed ID: 11814113
    [Abstract] [Full Text] [Related]

  • 29. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.
    J Immunol Methods; 2005 Mar 27; 298(1-2):35-45. PubMed ID: 15847795
    [Abstract] [Full Text] [Related]

  • 30. Detergent-activation of latent collagenase and resolution of its component molecules.
    Birkedal-Hansen H, Taylor RE.
    Biochem Biophys Res Commun; 1982 Aug 31; 107(4):1173-8. PubMed ID: 6291522
    [No Abstract] [Full Text] [Related]

  • 31. Construction and virulence testing of a collagenase mutant of Clostridium perfringens.
    Awad MM, Ellemor DM, Bryant AE, Matsushita O, Boyd RL, Stevens DL, Emmins JJ, Rood JI.
    Microb Pathog; 2000 Feb 31; 28(2):107-17. PubMed ID: 10644496
    [Abstract] [Full Text] [Related]

  • 32. The interaction of 1-anilino-8-naphthalene sulphonate with human C1q.
    Alcolea JM, Antón LC, Marqués G, Sánchez-Corral P, Vivanco F.
    Mol Immunol; 1986 Jan 31; 23(1):39-44. PubMed ID: 3007977
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Complement biosynthesis by the human hepatoma-derived cell line HepG2.
    Morris KM, Aden DP, Knowles BB, Colten HR.
    J Clin Invest; 1982 Oct 31; 70(4):906-13. PubMed ID: 6288774
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Collagen degradation by three Clostridium histolyticum collagenase fractions with different substrate specificities.
    Vos-Scheperkeuter GH, Vonk MW, Wolters GH, van Schilfgaarde R.
    Transplant Proc; 1994 Apr 31; 26(2):641-2. PubMed ID: 8171590
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.